课题基金 / 基金详情

Radiation therapy for thrombocytopenia due to splenomegaly of liver cirrhosis

Radiation therapy for thrombocytopenia due to splenomegaly of liver cirrhosis
肝硬化脾肿大所致血小板减少症的放射治疗
批准号:
22791221
负责人:
SUTANI Shinnya
金额:
$2.58万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2011

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Hepatocellular carcinoma(HCC) is naturally resistant toradiotherapy and cytotoxic chemotherapy, leaving surgery as the mainstream therapeuticapproach. On the other hand, it is well known that platelets have a thrombotic effect. However, platelets play an important role not only in hemostasis but also in wound healingand tissue regeneration. Platelets have been reported to accumulate in the liver andpromote liver regeneration after an extended hepatectomy, but the mechanism is unclear. The decrease of platelets of splenomegaly accompanying liver cirrhosis obstructs medicaltreatment, and gives up medical treatment in many cases. Radiation irradiation isconsidered as good adaptation, to splenomegaly by malignant tumors, such as a lymphoma, if the decrease of platelets improves by radiation irradiation in an example with a badreaction, etc. to chemotherapy is increasing also with the benign disease. The decreaseof platelets by hypersplenism accompanying liver cirrhosis is intractable, and can serveas the medical treatment method with effective radiotherapy. Here, the aims of this studyat exploring clinical application of the radiotherapy which is not the present insuranceadaptation as a cure for the plastocytopenia by the splenomegaly accompanying livercirrhosis in this research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金